Clinical trials
Carcinoma, Hepatocellular trials in Italy with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 3 |
| Humanitas Clinical and Research Center | 2 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2 |
| International Group of Endovascular Oncology | 2 |
| Azienda Ospedaliera Ordine Mauriziano di Torino | 1 |
| Azienda Ospedaliera di Padova | 1 |
| Azienda Ospedaliero Universitaria Policlinico Modena | 1 |
| Federico II University | 1 |
| Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 1 |
| Istituto Clinico Humanitas | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 22 |
| Liver Cirrhosis | 3 |
| Liver Neoplasms | 3 |
| Fibrosis | 2 |
| Recurrence | 2 |
| Esophageal and Gastric Varices | 1 |
| Fatty Liver | 1 |
| Hypertension, Portal | 1 |
| Kidney Neoplasms | 1 |
| Neoplastic Cells, Circulating | 1 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.